Industry: Medical Devices & Consumables
Published Date: 2026-01-19
Pages: 106 Pages
Report ld: 5725599
Request Sample
Customized Report
The global market for Breast Tissue Marker Localization Needle was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Breast Tissue Marker Localization Needle cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The breast tissue marker localization needle is an important medical device for the diagnosis and treatment of breast diseases. It is usually used to mark the location of suspected lesions before breast biopsy or surgery so that surgeons can accurately locate and remove the lesion area.
The North American market for Breast Tissue Marker Localization Needle was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Breast Tissue Marker Localization Needle was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Breast Tissue Marker Localization Needle was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Breast Tissue Marker Localization Needle market include BD, Cook, Argon Medical Devices, Pajunk, STERYLAB, Mammotome, CP Medical, Hologic, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Breast Tissue Marker Localization Needle, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Breast Tissue Marker Localization Needle market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Breast Tissue Marker Localization Needle.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Breast Tissue Marker Localization Needle manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Breast Tissue Marker Localization Needle sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Breast Tissue Marker Localization Needle sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Breast Tissue Marker Localization Needle Product Introduction
1.2 Global Breast Tissue Marker Localization Needle Market Size Forecast
1.2.1 Global Breast Tissue Marker Localization Needle Sales Value (2021–2032)
1.2.2 Global Breast Tissue Marker Localization Needle Sales Volume (2021–2032)
1.2.3 Global Breast Tissue Marker Localization Needle Sales Price (2021–2032)
1.3 Breast Tissue Marker Localization Needle Market Trends & Drivers
1.3.1 Breast Tissue Marker Localization Needle Industry Trends
1.3.2 Breast Tissue Marker Localization Needle Market Drivers & Opportunities
1.3.3 Breast Tissue Marker Localization Needle Market Challenges
1.3.4 Breast Tissue Marker Localization Needle Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Breast Tissue Marker Localization Needle Players Revenue Ranking (2025)
2.2 Global Breast Tissue Marker Localization Needle Revenue by Company (2021–2026)
2.3 Global Breast Tissue Marker Localization Needle Sales Volume Ranking of Players (2025)
2.4 Global Breast Tissue Marker Localization Needle Sales Volume by Company (2021–2026)
2.5 Global Breast Tissue Marker Localization Needle Average Price by Company (2021–2026)
2.6 Key Manufacturers Breast Tissue Marker Localization Needle Manufacturing Base and Headquarters
2.7 Key Manufacturers Breast Tissue Marker Localization Needle Product Offerings
2.8 Key Manufacturers Start of Mass Production of Breast Tissue Marker Localization Needle
2.9 Breast Tissue Marker Localization Needle Market Competitive Analysis
2.9.1 Breast Tissue Marker Localization Needle Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Breast Tissue Marker Localization Needle Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Breast Tissue Marker Localization Needle revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Breast Tissue Marker Localization Needle Market Classification
3.1 Introduction by Type
3.1.1 Double Barb
3.1.2 Single Barb
3.1.3 Other
3.1.4 Global Breast Tissue Marker Localization Needle Sales Value by Type
3.1.4.1 Global Breast Tissue Marker Localization Needle Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Breast Tissue Marker Localization Needle Sales Value, by Type (2021–2032)
3.1.4.3 Global Breast Tissue Marker Localization Needle Sales Value, by Type (%), 2021–2032
3.1.5 Global Breast Tissue Marker Localization Needle Sales Volume by Type
3.1.5.1 Global Breast Tissue Marker Localization Needle Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Breast Tissue Marker Localization Needle Sales Volume, by Type (2021–2032)
3.1.5.3 Global Breast Tissue Marker Localization Needle Sales Volume, by Type (%), 2021–2032
3.1.6 Global Breast Tissue Marker Localization Needle Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Breast Cancer Screening
4.1.2 Benign Breast Lesions
4.1.3 Preoperative Positioning
4.1.4 Others
4.2 Global Breast Tissue Marker Localization Needle Sales Value by Application
4.2.1 Global Breast Tissue Marker Localization Needle Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Breast Tissue Marker Localization Needle Sales Value, by Application (2021–2032)
4.2.3 Global Breast Tissue Marker Localization Needle Sales Value, by Application (%), 2021–2032
4.3 Global Breast Tissue Marker Localization Needle Sales Volume by Application
4.3.1 Global Breast Tissue Marker Localization Needle Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Breast Tissue Marker Localization Needle Sales Volume, by Application (2021–2032)
4.3.3 Global Breast Tissue Marker Localization Needle Sales Volume, by Application (%), 2021–2032
4.4 Global Breast Tissue Marker Localization Needle Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Breast Tissue Marker Localization Needle Sales Value by Region
5.1.1 Global Breast Tissue Marker Localization Needle Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Breast Tissue Marker Localization Needle Sales Value by Region (2021–2026)
5.1.3 Global Breast Tissue Marker Localization Needle Sales Value by Region (2027–2032)
5.1.4 Global Breast Tissue Marker Localization Needle Sales Value by Region (%), 2021–2032
5.2 Global Breast Tissue Marker Localization Needle Sales Volume by Region
5.2.1 Global Breast Tissue Marker Localization Needle Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Breast Tissue Marker Localization Needle Sales Volume by Region (2021–2026)
5.2.3 Global Breast Tissue Marker Localization Needle Sales Volume by Region (2027–2032)
5.2.4 Global Breast Tissue Marker Localization Needle Sales Volume by Region (%), 2021–2032
5.3 Global Breast Tissue Marker Localization Needle Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Breast Tissue Marker Localization Needle Sales Value, 2021–2032
5.4.2 North America Breast Tissue Marker Localization Needle Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Breast Tissue Marker Localization Needle Sales Value, 2021–2032
5.5.2 Europe Breast Tissue Marker Localization Needle Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Breast Tissue Marker Localization Needle Sales Value, 2021–2032
5.6.2 Asia Pacific Breast Tissue Marker Localization Needle Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Breast Tissue Marker Localization Needle Sales Value, 2021–2032
5.7.2 South America Breast Tissue Marker Localization Needle Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Breast Tissue Marker Localization Needle Sales Value, 2021–2032
5.8.2 Middle East & Africa Breast Tissue Marker Localization Needle Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Breast Tissue Marker Localization Needle Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Breast Tissue Marker Localization Needle Sales Value and Sales Volume
6.2.1 Key Countries/Regions Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.2.2 Key Countries/Regions Breast Tissue Marker Localization Needle Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.3.2 United States Breast Tissue Marker Localization Needle Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Breast Tissue Marker Localization Needle Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.4.2 Europe Breast Tissue Marker Localization Needle Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Breast Tissue Marker Localization Needle Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.5.2 China Breast Tissue Marker Localization Needle Sales Value by Type (%), 2025 vs 2032
6.5.3 China Breast Tissue Marker Localization Needle Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.6.2 Japan Breast Tissue Marker Localization Needle Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Breast Tissue Marker Localization Needle Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.7.2 South Korea Breast Tissue Marker Localization Needle Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Breast Tissue Marker Localization Needle Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.8.2 Southeast Asia Breast Tissue Marker Localization Needle Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Breast Tissue Marker Localization Needle Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Breast Tissue Marker Localization Needle Sales Value, 2021–2032
6.9.2 India Breast Tissue Marker Localization Needle Sales Value by Type (%), 2025 vs 2032
6.9.3 India Breast Tissue Marker Localization Needle Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 BD
7.1.1 BD Company Information
7.1.2 BD Introduction and Business Overview
7.1.3 BD Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 BD Breast Tissue Marker Localization Needle Product Offerings
7.1.5 BD Recent Developments
7.2 Cook
7.2.1 Cook Company Information
7.2.2 Cook Introduction and Business Overview
7.2.3 Cook Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Cook Breast Tissue Marker Localization Needle Product Offerings
7.2.5 Cook Recent Developments
7.3 Argon Medical Devices
7.3.1 Argon Medical Devices Company Information
7.3.2 Argon Medical Devices Introduction and Business Overview
7.3.3 Argon Medical Devices Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Argon Medical Devices Breast Tissue Marker Localization Needle Product Offerings
7.3.5 Argon Medical Devices Recent Developments
7.4 Pajunk
7.4.1 Pajunk Company Information
7.4.2 Pajunk Introduction and Business Overview
7.4.3 Pajunk Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Pajunk Breast Tissue Marker Localization Needle Product Offerings
7.4.5 Pajunk Recent Developments
7.5 STERYLAB
7.5.1 STERYLAB Company Information
7.5.2 STERYLAB Introduction and Business Overview
7.5.3 STERYLAB Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 STERYLAB Breast Tissue Marker Localization Needle Product Offerings
7.5.5 STERYLAB Recent Developments
7.6 Mammotome
7.6.1 Mammotome Company Information
7.6.2 Mammotome Introduction and Business Overview
7.6.3 Mammotome Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Mammotome Breast Tissue Marker Localization Needle Product Offerings
7.6.5 Mammotome Recent Developments
7.7 CP Medical
7.7.1 CP Medical Company Information
7.7.2 CP Medical Introduction and Business Overview
7.7.3 CP Medical Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 CP Medical Breast Tissue Marker Localization Needle Product Offerings
7.7.5 CP Medical Recent Developments
7.8 Hologic
7.8.1 Hologic Company Information
7.8.2 Hologic Introduction and Business Overview
7.8.3 Hologic Breast Tissue Marker Localization Needle Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Hologic Breast Tissue Marker Localization Needle Product Offerings
7.8.5 Hologic Recent Developments
8 Industry Chain Analysis
8.1 Breast Tissue Marker Localization Needle Industrial Chain
8.2 Breast Tissue Marker Localization Needle Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Breast Tissue Marker Localization Needle Sales Model
8.5.2 Sales Channels
8.5.3 Breast Tissue Marker Localization Needle Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Breast Tissue Marker Localization Needle market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 137
USD 4900.00
(Single User License)
The global Breast Tissue Marker Localization Needle market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 79
USD 4250.00
(Single User License)
The global Breast Tissue Marker Localization Needle market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 112
USD 2900.00
(Single User License)
The global Breast Tissue Marker Localization Needle market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 147
USD 4900.00
(Single User License)
The global Breast Tissue Marker Localization Needle market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
The global market for Breast Tissue Marker Localization Needle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 100
USD 3950.00
(Single User License)
The global market for Breast Tissue Marker Localization Needle was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
The breast tissue marker localization needle is an important medical device for the diagnosis and treatment of breast diseases. It is usually used to mark the location of suspected lesions before breast biopsy or surgery so that surgeons can accurately locate and remove the lesion area.
Published Date: 2024-08-11
Pages: 113
USD 4350.00
(Single User License)
The breast tissue marker localization needle is an important medical device for the diagnosis and treatment of breast diseases. It is usually used to mark the location of suspected lesions before breast biopsy or surgery so that surgeons can accurately locate and remove the lesion area.
Published Date: 2024-08-11
Pages: 85
USD 2900.00
(Single User License)
The breast tissue marker localization needle is an important medical device for the diagnosis and treatment of breast diseases. It is usually used to mark the location of suspected lesions before breast biopsy or surgery so that surgeons can accurately locate and remove the lesion area.
Published Date: 2024-08-11
Pages: 137
USD 4900.00
(Single User License)
The global Breast Tissue Marker Localization Needle market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 137
The global Breast Tissue Marker Localization Needle market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 79
The global Breast Tissue Marker Localization Needle market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 112
The global Breast Tissue Marker Localization Needle market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 147
The global Breast Tissue Marker Localization Needle market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
The global market for Breast Tissue Marker Localization Needle was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 100
The global market for Breast Tissue Marker Localization Needle was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 86
The breast tissue marker localization needle is an important medical device for the diagnosis and treatment of breast diseases. It is usually used to mark the location of suspected lesions before breast biopsy or surgery so that surgeons can accurately locate and remove the lesion area.
Published: 2024-08-11
Pages: 113
The breast tissue marker localization needle is an important medical device for the diagnosis and treatment of breast diseases. It is usually used to mark the location of suspected lesions before breast biopsy or surgery so that surgeons can accurately locate and remove the lesion area.
Published: 2024-08-11
Pages: 85
The breast tissue marker localization needle is an important medical device for the diagnosis and treatment of breast diseases. It is usually used to mark the location of suspected lesions before breast biopsy or surgery so that surgeons can accurately locate and remove the lesion area.
Published: 2024-08-11
Pages: 137
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now